The Globe and Mail
Published Tuesday, Mar. 19 2013, 6:30 PM EDT
Patients taking powerful cholesterol-lowering drugs may be putting their kidneys at risk, according to the results of a landmark Canadian study.
The researchers focused on “high-potency” statins – Crestor, Lipitor and Zocor – which are well known for their ability to significantly reduce cholesterol levels.